Correvio International (Acquired 2013) is Biotechnology in Switzerland that focus on GP IIb business. Founded in 2010. They cover business area such as manufacturer, wholesaler, pharmaceutical, outcome, critically ill patient, Aggrastat, a reversible GP IIb, IIIa inhibitor, use, Acute Coronary Syndrome, quick recovery.
2010
( 14 years old in 2024 )
GP IIb
-
Rue des Alpes 21
Case Postale
1201 Geneva
Switzerland
Private
manufacturerwholesalerpharmaceuticaloutcomecritically ill patientAggrastata reversible GP IIbIIIa inhibitoruseAcute Coronary Syndromequick recovery
* We use standard office opening hours in near Correvio International (Acquired 2013)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Correvio International (Acquired 2013) is Biotechnology business from Switzerland that founded in 2010 (14 years old in 2024), Correvio International (Acquired 2013) business is focusing on GP IIb.
Correvio International (Acquired 2013) headquarter office and corporate office address is located in Rue des Alpes 21 Case Postale 1201 Geneva Switzerland.
Correvio International (Acquired 2013) was founded in Switzerland.
In 2024, Correvio International (Acquired 2013) is currently focus on GP IIb sector.
Above is snippet of Google Trends for "GP IIb" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Correvio International (Acquired 2013), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
